This case was an application for a judicial review brought by the Applicants, Bayer Inc. and Regeneron Pharmaceuticals, Inc., for a review of a decision by the Minister of Health, issued through the Office of Submissions and Intellectual Property (OSIP), relating to the Patented Medicines (Notice of Compliance) (PMNOC) Regulations.